SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 8/4/2015 11:41:47 AM - Followers: 622 - Board type: Free - Posts Today: 44

Cellceutix Corporation (CTIX) 
 

 

http://cellceutix.com/
 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
CIK:  0001355250
 
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

 

Management:   http://cellceutix.com/team/
The above link is kept updated.
http://www.zoominfo.com/p/Daniel-Jorgensen/1064701588
 

 
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/

http://cellceutix.com/wp-content/uploads/2015/06/Cellceutix-Fact-Sheet-June-2015-flattened-1.pdf

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

http://eccmid.meetingexpert.net/ECCMID_546/poster_122533/program.aspx/anchor122533

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

http://eccmid.meetingexpert.net/ECCMID_546/poster_122353/program.aspx

 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:
EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275
 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


 
 

 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
Wiki
CTIX News: Special Profile Coming and 4 Analyst Reports 07/21/2015 07:00:00 AM
CTIX News: Undervalued and Underexposed NYSE-MKT Stock to be Profiled by Large Media Group and four brief reports 06/15/2015 07:00:00 AM
CTIX News: Special Profile & Four Companies Where Investors are Anticipating Success 06/03/2015 07:00:00 AM
CTIX News: *Special Analyst Alert* and 4 Companies that are Worth a Look 05/13/2015 07:00:00 AM
CTIX News: Quarterly Report (10-q) 05/11/2015 02:03:16 PM
PostSubject
#114702  Sticky Note Cellceutix Announces Ongoing Enrollment of Phase 2 Trial TOB 08/03/15 09:38:40 AM
#114611  Sticky Note Brilliant chart showing the true Cellceutix corporate development TOB 08/02/15 04:26:55 PM
#114061  Sticky Note There are details that will be outlined for BigKahuna 07/29/15 09:41:25 PM
#112962  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 07/24/15 02:10:27 PM
#111959  Sticky Note Cellceutix to Start Brilacidin Phase 3 Program in ABSSSI BigKahuna 07/20/15 07:41:11 AM
#87958  Sticky Note Cellceutix Reports Spleen Lesion 'Disappears' in Patient With starbuxsux 01/20/15 08:25:55 AM
#114907   This would be a wonderful time for Leo daydreaming2 08/04/15 11:46:29 AM
#114906   Then why the ovarian cancer trial? doubleupZW 08/04/15 11:41:47 AM
#114905   If you are a true long, the whole scottsmith 08/04/15 11:29:35 AM
#114904   They have shown safety only, all they need To infinity and beyond! 08/04/15 11:23:37 AM
#114903   All of our usual flippers are over at doubleupZW 08/04/15 11:16:24 AM
#114902   Aruda must have a gentleman's agreement with Leo TheHound 08/04/15 11:14:50 AM
#114901   Guess the manipulators are done selling? Maybe, the Rdunn88 08/04/15 11:05:05 AM
#114900   Since it is a fantasy universe then logic TheDane 08/04/15 11:01:29 AM
#114899   Let's pretend we are in some fantasy universe Loose Lips 08/04/15 10:58:12 AM
#114898   Yawn. Go CTIX. TheHound 08/04/15 10:48:07 AM
#114896   Bad news about Kevetrin? What BS. Phase 1 BigKahuna 08/04/15 09:46:14 AM
#114895   I'd really like to know how the ask keltoi 08/04/15 09:45:25 AM
#114894   By the "next ASCO", the B Phase 3 thefamilyman 08/04/15 09:32:50 AM
#114892   why not 90 percent? what are your thoughts? doubleupZW 08/04/15 09:13:56 AM
#114891   "Oh brother" is right! You've changed the question 1400 08/04/15 09:05:43 AM
#114890   if K works it is gold, much more To infinity and beyond! 08/04/15 09:00:59 AM
#114889   One of our better-informed [smarter? ;-)] posters has thefamilyman 08/04/15 08:59:08 AM
#114888   Of course it's speculation. Hope you're right. scottsmith 08/04/15 08:47:24 AM
#114887   Very telling chart for long term holders. Go CTIX! TheDane 08/04/15 08:43:50 AM
#114886   not speculation, just saying that this is how doubleupZW 08/04/15 08:42:11 AM
#114885   I actually think that you will see that doubleupZW 08/04/15 08:36:17 AM
#114884   We obviously have K news hiding in doubleupZW 08/04/15 08:32:33 AM
#114883   Oh brother- look: right now Brilacidin is a To infinity and beyond! 08/04/15 08:26:58 AM
#114882   I wasn't looking at it from a short 1400 08/04/15 08:14:37 AM
#114881   New analysis underscores improving pharma R&D productivity Echo20 08/04/15 08:13:08 AM
#114880   In the very long run yes To infinity and beyond! 08/04/15 07:54:36 AM
#114879   Researchers find biomarkers for early stage pancreatic cancer CallMeCrazy 08/04/15 07:46:48 AM
#114878   Quite simply if Brilacidin is a success your 1400 08/04/15 07:45:14 AM
#114877   Of course agree with you, with one caveat. To infinity and beyond! 08/04/15 07:23:41 AM
#114876   Don't forget there's a support line on the TheDane 08/04/15 07:12:09 AM
#114874   Where's the Bologna? Ever since I have followed To infinity and beyond! 08/04/15 06:58:53 AM
#114873   Thanks biodoc! for concise AND correctly scientific piece...my 1hb 08/04/15 04:00:16 AM
#114871   I got you beat... Bought my first at ROMAD Diver 08/04/15 03:23:50 AM
#114870   Nope, not a hit piece at all. Just ROMAD Diver 08/04/15 03:16:05 AM
#114869   Let's compare the CTIX chart to AVXL over KarinCA 08/04/15 02:41:39 AM
#114868   I see Google finance updated the company description Whoops 08/04/15 02:21:51 AM
#114866   BK, $2.40 is nowhere near the bottom. Have sox040713 08/04/15 01:15:32 AM
#114865   Please put up the clinical trial charts of sox040713 08/04/15 01:04:34 AM
#114863   It's the 10-K and its due on or thefamilyman 08/03/15 11:11:06 PM
#114862   Please stop throwing those facts around like that. Tails 08/03/15 11:03:56 PM
#114860   @VX1 ? have you look at the history lousy engineer 08/03/15 10:34:17 PM
#114859   I believe there's manipulation on the OTC and TheHound 08/03/15 10:28:23 PM
#114858   When is the next 10-q due we really Dynarod 08/03/15 10:04:33 PM
#114856   Waverunner1, fair enough. It's a long road biodoc 08/03/15 09:49:31 PM
#114855   On MM's wash trading and manipulating the PPS TheBunny 08/03/15 09:45:59 PM
#114854   Excellent post, I agree wholeheartedly with everything you Waverunner1 08/03/15 09:37:17 PM
#114853   Too bad there is no applause button, F1ash 08/03/15 09:34:23 PM
#114852   There was GREAT NEWS today regarding Cellceutix, but georgejjl 08/03/15 09:20:18 PM
#114851   Why are we here? Worth a look. noretreat 08/03/15 09:15:22 PM
#114850   If criminals control our stock thru wash trading TheHound 08/03/15 09:06:00 PM
PostSubject